XML 33 R7.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Restricted Stock Units (RSUs) [Member]
Common Stock [Member]
Performance Shares [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Noncontrolling Interest [Member]
Restricted Stock Units (RSUs) [Member]
Performance Shares [Member]
Total
Balance (in shares) at Dec. 31, 2017     32,462,542              
Issuance of common stock upon stock option exercises (in shares)     0              
Issuance of shares pursuant to restricted stock units (in shares) 301,041 296,909                
Issuance of shares pursuant to deferred stock units (in shares)     26,396              
Shares repurchased and retired (in shares)     (772,898)              
Balance (in shares) at Sep. 30, 2018     32,313,990              
Balance at Dec. 31, 2017     $ 325 $ 140,749 $ 376,694 $ (23,522) $ 10,810     $ 505,056
Issuance of common stock upon stock option exercises     0 0           0
Issuance of shares pursuant to restricted stock units $ 3 $ 3           $ 3 $ 3  
Issuance of shares pursuant to deferred stock units     0             0
Shares repurchased and retired     (8) (18,620)           (18,628)
Balance at Sep. 30, 2018     $ 323 128,330 382,367 (32,668) 7,732     486,084
Equity-based compensation expense       6,201           6,201
Cumulative effect adjustment (see Revenues: Note 3)         268         268
Net income (loss)         5,405   458     5,863
Currency translation adjustment and derivative transactions, net           (9,146) (175)     (9,321)
Distributions to non-controlling interests             0     0
Sale of non-controlling interests             (3,361)     (3,361)
Balance (in shares) at Jun. 30, 2018     32,303,638              
Issuance of common stock upon stock option exercises (in shares)     0              
Issuance of shares pursuant to restricted stock units (in shares) 5,621 0                
Issuance of shares pursuant to deferred stock units (in shares)     5,457              
Shares repurchased and retired (in shares)     (726)              
Balance (in shares) at Sep. 30, 2018     32,313,990              
Balance at Jun. 30, 2018     $ 323 127,242 382,814 (26,374) 10,433     494,438
Issuance of common stock upon stock option exercises     0 0           0
Issuance of shares pursuant to restricted stock units $ 0 $ 0           0 0  
Issuance of shares pursuant to deferred stock units     0             0
Shares repurchased and retired     0 (19)           (19)
Balance at Sep. 30, 2018     $ 323 128,330 382,367 (32,668) 7,732     486,084
Equity-based compensation expense       1,107           1,107
Cumulative effect adjustment (see Revenues: Note 3)         0         0
Net income (loss)         (447)   588     141
Currency translation adjustment and derivative transactions, net           (6,294) 72     (6,222)
Distributions to non-controlling interests             0     0
Sale of non-controlling interests             (3,361)     $ (3,361)
Balance (in shares) at Dec. 31, 2018     31,922,409             31,922,409
Issuance of common stock upon stock option exercises (in shares)     52,783             52,783
Issuance of shares pursuant to restricted stock units (in shares) 222,745 111,158                
Issuance of shares pursuant to deferred stock units (in shares)     84,184              
Shares repurchased and retired (in shares)     (1,585,731)              
Balance (in shares) at Sep. 30, 2019     30,807,548             30,807,548
Balance at Dec. 31, 2018     $ 319 122,818 379,890 (40,290) 7,450     $ 470,187
Issuance of common stock upon stock option exercises     1 955           956
Issuance of shares pursuant to restricted stock units $ 2 $ 1           2 1  
Issuance of shares pursuant to deferred stock units     1             1
Shares repurchased and retired     (16) (28,127)           (28,143)
Balance at Sep. 30, 2019     $ 308 101,627 373,559 (43,626) 6,576     438,444
Equity-based compensation expense       5,981           5,981
Cumulative effect adjustment (see Revenues: Note 3)         0         0
Net income (loss)         (6,331)   542     (5,789)
Currency translation adjustment and derivative transactions, net           (3,336) (7)     (3,343)
Distributions to non-controlling interests             (1,409)     (1,409)
Sale of non-controlling interests             0     $ 0
Balance (in shares) at Jun. 30, 2019     30,941,394              
Issuance of common stock upon stock option exercises (in shares)     0              
Issuance of shares pursuant to restricted stock units (in shares) 17,471 0                
Issuance of shares pursuant to deferred stock units (in shares)     6,698              
Shares repurchased and retired (in shares)     (158,015)              
Balance (in shares) at Sep. 30, 2019     30,807,548             30,807,548
Balance at Jun. 30, 2019     $ 309 102,841 367,523 (42,940) 6,290     $ 434,023
Issuance of common stock upon stock option exercises     0 0           0
Issuance of shares pursuant to restricted stock units $ 0 $ 0           $ 0 $ 0  
Issuance of shares pursuant to deferred stock units     0             0
Shares repurchased and retired     (1) (2,971)           (2,972)
Balance at Sep. 30, 2019     $ 308 101,627 373,559 (43,626) 6,576     438,444
Equity-based compensation expense       $ 1,757           1,757
Cumulative effect adjustment (see Revenues: Note 3)         0         0
Net income (loss)         $ 6,036   313     6,349
Currency translation adjustment and derivative transactions, net           $ (686) (27)     (713)
Distributions to non-controlling interests             0     0
Sale of non-controlling interests             $ 0     $ 0